Studies of the mechanism of epidermal injury by a Staphylococcal epidermolytic toxin.
Experimental animal models of the two forms of toxic epidermal necrolysis have been reviewed: a murine model of staphylococcal-induced epidermolysis and a hamster model of graft-versus-host disease. In the former, a protein exotoxin, epidermolysin, has been purified and characterized. The exotoxin has a molecular weight of approximately 30,000 and causes a split beneath the granular layer. It is effective at 3 times 10(-12) moles. Epidermolysin does not require an intact complement system for its action since B10D2 mice deficient in C5 or mice injected with the decomplementing agent in cobra venom factor were susceptible to its epidermolytic effects. Neither are immunocompetent thymocytes required for the action of the toxin since hairless, athymic adult (nu/nu) mice are susceptible. A few reports of epidermolysis due to an exotoxin of group I Staphylococcus aureus have appeared. This toxin is antigenically different from the exotoxin of group II organisms. A model of drug-induced toxic epidermal necrolysis has been described in hamsters, but the toxic principle released from sensitized lymphoid cells has not yet been characterized.
D000818:Animals; D000941:Antigens / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D002845:Chromatography; D003165:Complement System Proteins / Q000032:analysis; D006224:Cricetinae; D003483:Cutis Laxa / Q000139:chemically induced*; D004195:Disease Models, Animal; D004586:Electrophoresis; D006087:Graft vs Host Reaction / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D051379:Mice; D008815:Mice, Inbred Strains; D012867:Skin / Q000293:injuries* / Q000473:pathology; D013208:Staphylococcal Toxoid / Q000009:adverse effects / Q000494:pharmacology*; D013204:Staphylococcus Phages / Q000302:isolation & purification; D013262:Stevens-Johnson Syndrome / Q000276:immunology / Q000503:physiopathology*; D013950:Thymus Gland / Q000032:analysis
D000941:Antigens; D013208:Staphylococcal Toxoid; D003165:Complement System Proteins